BioNxt Solutions Inc. filed its Annual on Apr 12, 2023 for the period ending Dec 31, 2022. In this report its auditor, Davidson & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 CAD | +11.11% | +1.27% | -17.53% |
Apr. 26 | BioNxt Solutions Inc. Announces ODF Cladribine Update | CI |
Apr. 26 | BioNxt Solutions Inc. announced that it expects to receive CAD 1.62 million in funding | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.53% | 32M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- BNXT Stock
- News BioNxt Solutions Inc.
- BioNxt Solutions Inc. Auditor Raises 'Going Concern' Doubt